Citation Impact

Citing Papers

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Expanding global access to radiotherapy
2015 Standout
Hepatobiliary complications in patients with human immunodeficiency virus infection
1992
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Cancer Statistics, 2006
2006 Standout
TFOS DEWS II pathophysiology report
2017 Standout
TFOS DEWS II Epidemiology Report
2017 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures
2002
Past, present, and future of radiotherapy for the benefit of patients
2012
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation
2004
Radiotherapy-induced thyroid disorders
2004
TFOS DEWS II Sex, Gender, and Hormones Report
2017
Review of clinical radioimmunotherapy
2006
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Human microsporidial infections
1994 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
2004
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
2002
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
2006
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Guidelines for the management of thyroid cancer
2014 Standout
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
2007
A Questionnaire-Based Assessment of Symptoms Associated with Tear Film Dysfunction and Lid Margin Disease in an Asian Population
2009

Works of A. Lisbona being referenced

Voxeldose: A Computer Program for 3-D Dose Calculation in Therapeutic Nuclear Medicine
2003
Avis du groupe de travail missionné par l’Autorité de sûreté nucléaire concernant la radiothérapie stéréotaxique
2012
Multifocal cytomegalovirus-associated hepatic lesions simulating metastases in AIDS.
1990
Long-term complications of total body irradiation in adults
2001
Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer.
1996
Rankless by CCL
2026